|
 |
News and Press Releases
|
July 31,
2008 |
|
JT Reports Consolidated Financial Results for the First Quarter that Ended June 30, 2008 |
|
May 1,
2008 |
|
JT Reports Consolidated Financial Results
For the Full Fiscal Year that Ended March 31, 2008 |
|
February 7,
2008 |
|
JT Reports Consolidated Financial Results For the Nine-Month Period that Ended December 31, 2007 |
|
October 31,
2007 |
|
JT Reports Consolidated Financial Results for the First Fiscal Half that Ended September 30, 2007 |
|
September 26,
2007 |
|
JT and Torii Sign Licensing Agreement with Keryx for Development and Commercialization of Hyperphosphatemia Drug in Japan |
|
August 9,
2007 |
|
JT Announces its First-Quarter Consolidated Financial Results and Gallaher Integration Plan(PDF file) |
|
April 27,
2007 |
|
JT Reports Consolidated Financial Results for the Full Fiscal Year that Ended March 31, 2007(PDF file) |
|
February 8,
2007 |
|
JT Reports Consolidated Financial Results for the Nine-Month Period that Ended December 31, 2006 (PDF file) |
|
December 28,
2006 |
|
JT Announces Licensing Agreement for New Antibody Drug Candidate with MedImmune |
|
November 28,
2006 |
|
New Drug Application of Antipruritic Agent "TRK-820" for the Treatment of Severe Pruritus in Hemodialysis Patients in Japan |
|
October 31,
2006 |
|
JT Reports Consolidated Interim Financial Results For the First Fiscal Half that Ended September 30, 2006(PDF file) |
|
July 31,
2006 |
|
JT Reports Consolidated Financial Results for the First Quarter that Ended June 30, 2006(PDF file) |
|
April 28,
2006 |
|
JT Reports Consolidated Financial Results for the Full Fiscal Year that Ended March 31, 2006(PDF file) |
|
April 18,
2006 |
|
JT Concludes
Licensing Agreement for a New Drug Candidate with GlaxoSmithKline |
|
February 17,
2006 |
|
JT
Reports Consolidated Financial Results for the Nine Month Period That
Ended December 31, 2005(PDF file) |
|
October 31,
2005 |
|
JT
Reports Consolidated Interim Financial Results For the First Fiscal Half That
Ended September 30, 2005(PDF file) |
|
August 1,
2005 |
|
JT
Reports Consolidated Financial Results for the First Quarter that
Ended June 30, 2005 (PDF file) |
|
April 27,
2005 |
|
JT
Reports Consolidated Financial Results for the Fiscal Year that
Ended March, 2005 (PDF file) |
|
April 22,
2005 |
|
JT
Group to Merge Pharmaceutical Production Facilities |
|
April 8,
2005 |
|
JT
and Torii Pharmaceutical to Launch New HIV Treatment Drugs in
Japan |
|
March 22,
2005 |
|
JT
Concludes License Agreement on JT's Anti-HIV drug with Gilead |
|
March 16,
2005 |
|
Toray,
JT, Torii Pharmaceutical Agree Co-development and
Marketing |
|
February 17,
2005 |
|
JT's
consolidated Financial Results for the Nine-Month Period that
Ended December 31, 2004 (PDF file) |
|
October 29,
2004 |
|
JT's
consolidated Interim Results for the First Half that Ended September
30, 2004 (PDF file) |
|
October 24,
2004 |
|
JT
and Roche Conclude Licensing Agreement on JT's Dyslipidemia
Compound |
|
©2007 Akros Pharma Inc. All rights
reserved. |
|